Equest Pramox - Paste - Horse Wormer
One tube of Equest Pramox will treat a horse up to 700kg.
A clear gel containing
and 220.0 mg/g benzyl alcohol and 0.80 mg/g butyl hydroxytoluene as preservatives/antioxidants.
Many doses of EQUEST PRAMOX have been safely given to horses of all kinds and research has shown it is safe to use in pregnant and lactating mares, stallions and foals over 6 1/2 months of age. The dosing interval of Equest Pramox is the longest of any horse wormer at 13 weeks
Do NOT use Equest Pramox on donkeys. Equest Pramox is the only horse wormer with a 2 week persistent action. Equest has the remarkably long duration of action worming horses for 13 weeks.
Equest Pramox treats all common horse worms , including Tapeworms, Bots (Bot fly larvae) and developing and inhibited encysted small redworms at the standard dose. Equest is licensed to control benzimidazole resistant strains of cyathostomins. Containing the active ingredient Moxidectin Equest is the first new molecule for a horse wormer since the introduction of ivermectin.
Use Pramox in conjunction with Equest every quarter for a years complete worming programme. Equest Pramox has no current confirmed resistance in horses in the UK or Ireland. EQUEST PRAMOX is kind to the environment. With lower toxicity to dung dwelling insects than ivermectin-based wormers, insects can carry on cleaning the pasture of dung.
Do not use Equest Pramox for sick or debilitated horses
After opening, use within 6 months. Do not store above 25°C. Keep the syringe in the carton. After first use record the date to be disposed on the label space provided
Dosage and Administration
For oral administration. One 12.2g syringe contains sufficient gel to treat one 700 kg horse at the recommended dose rate (0.4 mg moxidectin per kg bodyweight). Each graduation on the calibrated syringe delivers sufficient gel to treat 25 kg bodyweight. Use of a scale or weigh tape is recommended to ensure accurate dosing. To avoid overdosing, care should be taken to accurately dose foals, especially low bodyweight foals or young ponies.
Further Information - Transient adverse reactions may occur at twice the recommended dose in foals and 3 times the recommended dose in adults. The signs are depression, inappetence, ataxia and drooping lower lip 8 to 24 hours following dosing. Symptoms of moxidectin overdose are the same as those observed in very rare occasions at the recommended dosage. In addition, hypothermia may occur. Symptomatic treatment is not generally necessary and recovery is generally complete within 24 to 72 hours. There is no specific antidote.
Important Safety Information
You need to read all of the instructions and warnings on the leaflets inserted in the packaging and you confim in the questions that you will do so before any handling or administration of the product. You need to be aware that some products can not be used during pregnancy or lactation and you must check before use. You must also be aware that some products may react with other treatments if the animal is on medication and we recommend that you must check with your vet before administration of any other medications.
By proceeding with the checkout process, you agree that you have read, understood and accepted the statements above and have completed the questions as true to the best of your knowledge.
This product is only for sale after confirmation that it is suitable for your use. Our SQP's may contact you to confirm your information before dispatching this item. Please ensure you leave your correct contact details and number - if you are not contactable the order will be cancelled as this product cannot be sold without first checking that it is suitable for your animals needs.
Link to Product Safety Data Sheet
Link to product Datasheet on NOAH
Link to VMD product information Database